IN BRIEF: Ananda gets NHS funding for CBD oil endometriosis trial

Ananda Developments PLC - London-based pharmaceutical company developing cannabinoid-based ...

Alliance News 15 August, 2023 | 10:07AM
Email Form Facebook Twitter LinkedIn RSS

Ananda Developments PLC - London-based pharmaceutical company developing cannabinoid-based medicines for chronic pain conditions - Says the Scottish government's Chief Scientist Office, responsible for funding research in NHS Scotland, will provide non-dilutive funding for Ananda's randomised controlled trial. The RCT will test Ananda's MRX1 sublingual cannabidiol (CBD) oil formulation versus a matching placebo, in 100 endometriosis patients. Endometriosis is a chronic condition affecting roughly 190 million people assigned female at birth worldwide. Ananda intends to "investigate if a future large scale, UK-wide trial to determine whether a cannabinoid can reduce endometriosis-associated pain is possible."

Chief Executive Officer Melissa Sturgess says: "Our objective is to have MRX1 included by the NHS as an efficacious and cost-effective treatment for pain associated with endometriosis. Getting NHS funding for this trial using MRX1 is a clear statement of the importance of endometriosis as a public health issue and we believe clearly demonstrates the interest in the use of cannabidiol as a potential treatment for endometriosis and other complex chronic inflammatory pain conditions by the UK's public health bodies."

Current stock price: 0.45 pence, up 3.3% on Tuesday in London

12-month change: down 13%

By Emma Curzon, Alliance News reporter

Comments and questions to

Copyright 2023 Alliance News Ltd. All Rights Reserved

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Ananda Developments PLC Ordinary Shares 0.38 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures